Advertisement

The Latest

Tim Springer, PhD, an immunologist and professor of biological chemistry and molecular pharmacology at Boston-based Harvard Medical School, has donated $210 million to the Institute for Protein Innovation, a nonprofit research organization that focuses on protein science, according to a…

Burkhard Blank, MD, has been appointed chief medical officer and executive vice president of research and development for biopharmaceutical company MannKind.

Companies announced 565 CEO exits in the first four months of 2023, according to one new analysis.

Advertisement